Recent findings in idiopathic membranous nephropathy (MN) suggest that in most patients,
the disease is because of anti-phospholipase A 2 receptor (PLA 2 R1) autoantibodies. Our …

About 70% of patients with primary membranous nephropathy (MN) have circulating anti-
phospholipase A 2 receptor (PLA 2 R) antibodies that correlate with disease activity, but …

Background The predictive value of anti-M-type phospholipase A2 receptor (PLA2R1)
autoantibodies for membranous nephropathy (MN) recurrence after renal transplantation …

The M-type phospholipase A2 receptor (PLA2R) is a target autoantigen in adult idiopathic
membranous nephropathy (MN), but the prevalence of autoantibodies against PLA2R is …

The M-type phospholipase A2 receptor (PLA 2 R) is the major target antigen in idiopathic
membranous nephropathy with detectable autoantibodies in the serum of up to 70% of …

Background Secretory phospholipase A2 receptor (PLA2R) is the target antigen of the auto-
antibodies produced in most (∼ 70%) patients with primary membranous nephropathy …

Objectives: Autoantibodies against the M-type phospholipase A2 receptor 1 (anti-PLA2R1)
have been demonstrated to be very specific for idiopathic membranous nephropathy (MN) …

Background Idiopathic membranous nephropathy, a common form of the nephrotic
syndrome, is an antibody-mediated autoimmune glomerular disease. Serologic diagnosis …

Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults,
with an uncertain clinical outcome. The characterization of the phospholipase A 2 receptor …

Results 77.8% of iMN patients in our cohort had antibodies reactive with human PLA 2 R.
The antibody levels in these patients correlated strongly with both clinical status and …